Insider Transactions in Q1 2025 at Wave Life Sciences Ltd. (WVE)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 20
2025
|
Christian O Henry |
SELL
Open market or private sale
|
Direct |
10,500
-39.45%
|
$94,500
$9.77 P/Share
|
|
Mar 20
2025
|
Christian O Henry |
BUY
Exercise of conversion of derivative security
|
Direct |
10,500
+28.29%
|
$94,500
$9.13 P/Share
|
|
Mar 07
2025
|
Paul Bolno President and CEO |
SELL
Open market or private sale
|
Direct |
169,025
-33.31%
|
$1,521,225
$9.57 P/Share
|
|
Mar 07
2025
|
Paul Bolno President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
169,025
+24.99%
|
$338,050
$2.48 P/Share
|
|
Mar 07
2025
|
Gregory L. Verdine |
BUY
Exercise of conversion of derivative security
|
Direct |
133,402
+29.92%
|
$266,804
$2.48 P/Share
|
|
Mar 05
2025
|
Gregory L. Verdine |
BUY
Exercise of conversion of derivative security
|
Direct |
133,000
+42.61%
|
$266,000
$2.48 P/Share
|
|
Mar 04
2025
|
Chandra Vargeese |
BUY
Exercise of conversion of derivative security
|
Direct |
91,754
+20.19%
|
$183,508
$2.48 P/Share
|
|
Feb 04
2025
|
Chandra Vargeese |
BUY
Grant, award, or other acquisition
|
Direct |
37,000
+12.02%
|
-
|
|
Feb 04
2025
|
Chris Francis |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+50.0%
|
-
|
|
Feb 04
2025
|
Paul Bolno President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
121,000
+26.34%
|
-
|
|
Feb 04
2025
|
Kyle Moran Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
42,000
+32.01%
|
-
|
|
Jan 23
2025
|
Chandra Vargeese |
BUY
Exercise of conversion of derivative security
|
Direct |
46,000
+16.43%
|
$92,000
$2.48 P/Share
|